Consider it the fulfillment of President Donald Trump's campaign promise to bring down drug prices in the U.S. That's how White House Budget Director Mick Mulvaney framed the administration's proposal to give the FDA a hefty spending hike in fiscal 2019 through user fees and tax dollars.